Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer

NCT01109524 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Neoplasms
Carcinoma
Cancer of the Lung
Non-Small-Cell Lung Carcinoma

Interventions

DRUG: Cetuximab
DRUG: Cisplatin
DRUG: Vinorelbine

Sponsor

Eli Lilly and Company